Status:
RECRUITING
Automated Sperm Selection
Lead Sponsor:
Create Fertility Center
Collaborating Sponsors:
University of Toronto
Conditions:
Infertility
Eligibility:
All Genders
19-43 years
Phase:
NA
Brief Summary
Intracytoplasmic sperm injection (ICSI) is one of the standard clinical treatments for infertility. ICSI involves the injection of a single sperm into an oocyte with a sharp micropipette. Injecting a ...
Detailed Description
Intracytoplasmic sperm injection (ICSI) is one of the standard clinical treatments for infertility. ICSI involves the injection of a single sperm into an oocyte with a sharp micropipette. Injecting a ...
Eligibility Criteria
Inclusion
- Patients undergoing ICSI
- Female partner between 19-43 years of age using own or donor oocytes
Exclusion
- Patients who do not provide informed consent
- Patients with less than 6 mature eggs collected
- Patients undergoing IVF without ICSI
- Morphology \<4% normal forms
- 100% immotile sperm
- Cases where surgically-retrieved sperm is used for ICSI
Key Trial Info
Start Date :
January 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT05240469
Start Date
January 20 2021
End Date
September 30 2024
Last Update
March 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CReATe Fertility Centre
Toronto, Ontario, Canada, M5G 1N8